Inicia sesión Registrate Mi Biblioteca biblioteca abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por la International Parkinson & Movement Disorder Society.

2014

8065 ARTíCULOS , VIENDO DEL 1 AL 15

PUBMED

Alzheimer's disease: new data highlight nonneuronal cell types and the necessity for presymptomatic prevention strategies

Gandy S.

Biol Psychiatry. 2014 Apr 1;75(7):553-7. doi: 10.1016/j.biopsych.2013.11.019. Epub 2013 Nov 28.

0

0

0

PUBMED

Effect of donepezil in Alzheimer disease can be measured by a computerized human analog of the Morris water maze

Hort J, Andel R, Mokrisova I, Gazova I, Amlerova J, Valis M, Coulson EJ, Harrison J, Windisch M, Laczó J.

Neurodegener Dis. 2014;13(2-3):192-6. doi: 10.1159/000355517. Epub 2013 Oct 30.

0

0

0

PUBMED

Impact of ambulatory physiotherapy on motor abilities of elderly subjects with Alzheimer's disease

Manckoundia P, Taroux M, Kubicki A, Mourey F.

Geriatr Gerontol Int. 2014 Jan;14(1):167-75. doi: 10.1111/ggi.12075. Epub 2013 Apr 25.

0

0

0

PUBMED

[Rivastigmine as treatment for patients with mild to moderately severe Alzheimer disease under normal clinical practice conditions. The ENTERPRISE study]

Cruz Jentoft AJ, Hernández B.

Neurologia. 2014 Jan-Feb;29(1):1-10. doi: 10.1016/j.nrl.2013.01.008. Epub 2013 Apr 10.

0

0

0

PUBMED

A small molecule that displays marked reactivity toward copper- versus zinc-amyloid-β implicated in Alzheimer's disease

Savelieff MG, Liu Y, Senthamarai RR, Korshavn KJ, Lee HJ, Ramamoorthy A, Lim MH.

Chem Commun (Camb). 2014 May 25;50(40):5301-3. doi: 10.1039/c3cc48473d. Epub 2013 Dec 10.

0

0

0

PUBMED

[Diagnosis and treatment of dementia: overview]

Furukawa K, Ishiki A, Tomita N, Arai H.

Rinsho Shinkeigaku. 2014;54(12):1171-3. doi: 10.5692/clinicalneurol.54.1171.

0

0

0

PUBMED

The effect of souvenaid on functional brain network organisation in patients with mild Alzheimer's disease: a randomised controlled study

de Waal H, Stam CJ, Lansbergen MM, Wieggers RL, Kamphuis PJ, Scheltens P, Maestú F, van Straaten EC.

PLoS One. 2014 Jan 27;9(1):e86558. doi: 10.1371/journal.pone.0086558. eCollection 2014.

0

0

0

PUBMED

Efficacy and safety of memantine in patients with moderate-to-severe Alzheimer's disease: results of a pooled analysis of two randomized, double-blind, placebo-controlled trials in Japan

Nakamura Y, Kitamura S, Homma A, Shiosakai K, Matsui D.

Expert Opin Pharmacother. 2014 May;15(7):913-25. doi: 10.1517/14656566.2014.902446. Epub 2014 Mar 27.

0

0

0

PUBMED

[Nursing care of residents with diabetes. More autonomy in managing diabetes despite dementia]

Jaunin MK.

Krankenpfl Soins Infirm. 2014;107(9):11-3, 56-8, 78-80.

0

0

0

PUBMED

A randomized, double-blind, placebo-controlled, 16-week study of the H3 receptor antagonist, GSK239512 as a monotherapy in subjects with mild-to-moderate Alzheimer's disease

Grove RA, Harrington CM, Mahler A, Beresford I, Maruff P, Lowy MT, Nicholls AP, Boardley RL, Berges AC, Nathan PJ, Horrigan JP.

Curr Alzheimer Res. 2014 Jan;11(1):47-58. doi: 10.2174/1567205010666131212110148.

0

0

0

PUBMED

Effects of functional tasks exercise on older adults with cognitive impairment at risk of Alzheimer's disease: a randomised controlled trial

Law LL, Barnett F, Yau MK, Gray MA.

Age Ageing. 2014 Nov;43(6):813-20. doi: 10.1093/ageing/afu055. Epub 2014 May 21.

0

0

0

PUBMED

Management of cognitive determinants in senile dementia of Alzheimer's type: therapeutic potential of a novel polyherbal drug product

Sadhu A, Upadhyay P, Agrawal A, Ilango K, Karmakar D, Singh GP, Dubey GP.

Clin Drug Investig. 2014 Dec;34(12):857-69. doi: 10.1007/s40261-014-0235-9.

0

0

0

PUBMED

Toward onset prevention of cognitive decline in adults with Down syndrome (the TOP-COG study): study protocol for a randomized controlled trial

Cooper SA, Caslake M, Evans J, Hassiotis A, Jahoda A, McConnachie A, Morrison J, Ring H, Starr J, Stiles C, Sullivan F.

Trials. 2014 Jun 3;15:202. doi: 10.1186/1745-6215-15-202.

0

0

0

PUBMED

Retrospective study on the benefits of combined Memantine and cholinEsterase inhibitor treatMent in AGEd Patients affected with Alzheimer's Disease: the MEMAGE study

Gareri P, Putignano D, Castagna A, Cotroneo AM, De Palo G, Fabbo A, Forgione L, Giacummo A, Lacava R, Marino S, Simone M, Zurlo A, Putignano S.

J Alzheimers Dis. 2014;41(2):633-40. doi: 10.3233/JAD-132735.

0

0

0

PUBMED

Safety profile of semagacestat, a gamma-secretase inhibitor: IDENTITY trial findings

Henley DB, Sundell KL, Sethuraman G, Dowsett SA, May PC.

Curr Med Res Opin. 2014 Oct;30(10):2021-32. doi: 10.1185/03007995.2014.939167. Epub 2014 Jul 14.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neuroacademy